Humana Inc vs ProShares UltraPro QQQ ETF — how do they compare? Humana Inc trades at $442.6 (market cap $47.61B), while ProShares UltraPro QQQ ETF trades at $82.11 (market cap $40.39B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and ProShares UltraPro QQQ ETF for 24 Days on average.
| HUM | TQQQ | |
|---|---|---|
Market Cap | $47.61B | $40.39B |
Volume | 1,827,332 | 37,786,708 |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.85 | $87.22 |
52-Week Low | $163.67 | $37.89 |
Typical Hold Time | 53 Days | 24 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
TQQQ, a 3x leveraged ETF tracking the Nasdaq-100, trades at $83.6, down 0.77% on the day. Technical indicators show a bullish trend with moving averages supporting upside momentum, though oscillators are neutral and RSI levels suggest potential overbought conditions. Recent news highlights concerns over hidden costs and volatility decay, while institutional activity shows mixed positioning. The fund's performance remains tied to the tech-heavy index, with AI-driven earnings from components being a key catalyst.
The outlook for TQQQ is cautiously optimistic, driven by strong tech sector earnings and bullish technical trends, but risks include amplified losses during market downturns, high expense ratios, and volatility decay. Investors should weigh the leveraged structure's benefits against potential drawdowns, with attention to upcoming tech earnings and broader market sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →